The fact is, researchers and doctors find it much easier to raise funds for drug evaluation studies than for treatments that do not hold out the promise of huge profits for anyone. Pharmaceutical companies, the major source of research dollars, have no incentive to support alternative approaches that will do nothing for the size of their coffers.
